You know the symptoms: your studies are scaling, but your supply chain was built for half this volume. Shipments and labels crawl through processes nobody can fully explain, on systems designed for commercial production, not clinical trials. SOPs are missing, outdated, or unreadable, and the next inspection or the next new hire will find that out the hard way. And if you are moving from clinical to commercial, the gap between the two keeps you up at night.

Here is the cost that doesn't show up on a dashboard: every week lost in the supply chain is a week a patient spends waiting for the therapy your science already proved. It doesn't have to work this way.

I'm Steve Jacobs - pharmacist, U.S. Army veteran and maintenance test pilot, and clinical supplies leader at Otsuka, McNeil, and Johnson & Johnson before founding Global BioPharm Solutions in 2007. I've spent 30 years finding what's slowing supply chains down - and fixing it. I've run supply chains, led the global operations of a clinical supplies contract organization, and trained thousands of the industry's professionals. If there's a way a clinical supply chain can break, I've probably seen it - and helped somebody fix it.

"If I can help you avoid the mistakes I've made, or seen others make, that makes my day."